Comparative Study of Ologen Collagen Matrix Versus Mitomycin-C in Glaucoma Filtering Surgery
Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
The objective of this prospective randomised study is to compare the efficacy and safety of
ologen CM (Collagen matrix) and Mitomycin-C (MMC) as adjuncts to filtration surgery in
uncontrolled treated glaucoma cases, the efficacy being the primary objective and the safety
being the secondary.
Phase:
Phase 4
Details
Lead Sponsor:
Aeon Astron Europe B.V.
Collaborators:
Glaucoma Associates of New York Robert Ritch, MD, LLC. The New York Eye & Ear Infirmary